NCT05043792View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Healthy
Interventions
DRUG

TT-00920

TT-00920 Tablets

DRUG

TT-00920 Placebo

TT-00920 Placebo Tablets

Trial Locations (1)

21201

Pharmaron CPC, Inc., Baltimore

All Listed Sponsors
lead

TransThera Sciences (Nanjing), Inc.

INDUSTRY

NCT05043792 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects | Biotech Hunter | Biotech Hunter